| Etanercept |
EU/1/99/126/020 |
ENBREL 50 mg solution for injection in pre-filled pen 50 mg/ml – 1 ml x 4 pre-filled pens +4 alcohol swabs, Solution for injection, 50, mg, Pack: 4 |
Pfizer Limited, Обединено Кралство |
Wyeth Pharmaceuticals New Lane Havant Hampshire, PO9 2NG, Обединено кралство |
1561.96 |
312.39 |
1874.35 |
4% |
10 |
1571.96 |
314.39 |
1886.35 |
16% |
25 |
1596.96 |
319.39 |
1916.35 |
|
НСР-6072/23.04.2015. |
08.05.2015 |
08.05.2015 |
Неактивен |
3823 |
| Etanercept |
EU/1/99/126/017 |
ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 |
Pfizer Europe MA EEIG, Обединено Кралство |
Wyeth Pharmaceuticals, UK |
1405.36 |
281.07 |
1686.43 |
4% |
10 |
1415.36 |
283.07 |
1698.43 |
16% |
25 |
1440.36 |
288.07 |
1728.43 |
|
НСР-7813/28.12.2015 |
13.01.2016 |
13.01.2016 |
Неактивен |
3736 |
| Etanercept |
EU/1/99/126/017 |
ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 |
Pfizer Europe MA EEIG, Обединено Кралство |
Wyeth Pharmaceuticals, UK |
1561.96 |
312.39 |
1874.35 |
4% |
10 |
1571.96 |
314.39 |
1886.35 |
16% |
25 |
1596.96 |
319.39 |
1916.35 |
|
НСР-5949/01.04.2015. |
16.04.2015 |
16.04.2015 |
Неактивен |
3736 |
| Etanercept |
EU/1/99/126/017 |
ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 |
Pfizer Limited, Обединено Кралство |
Wyeth Pharmaceuticals, UK |
1622.03 |
324.41 |
1946.44 |
4% |
10 |
1632.03 |
326.41 |
1958.44 |
16% |
25 |
1657.03 |
331.41 |
1988.44 |
|
НСР-3992/30.06.2014 |
15.07.2014 |
15.07.2014 |
Неактивен |
3736 |
| Etanercept |
EU/1/99/126/017 |
ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 |
Pfizer Limited, Обединено Кралство |
Wyeth Pharmaceuticals, UK |
1739.08 |
347.82 |
2086.9 |
4% |
10 |
1749.08 |
349.82 |
2098.9 |
16% |
25 |
1774.08 |
354.82 |
2128.9 |
оставена без разглеждане жалба до Комисия по прозрачност с решение на Комисия по прозрачност КП-241/28.06.2013; |
КЦРР-2426/22.02.2013 |
16.10.2013 |
16.10.2013 |
Неактивен |
3736 |
| Etanercept |
EU/1/99/126/017 |
ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 |
Pfizer Limited, Обединено Кралство |
Wyeth Pharmaceuticals, UK |
1852.6 |
370.52 |
2223.12 |
4% |
10 |
1862.6 |
372.52 |
2235.12 |
16% |
25 |
1887.6 |
377.52 |
2265.12 |
промяна в обстоятелствата КЦPP-1521/25.10.2012 |
КЦ-316/28.11.2008 |
19.12.2008 |
19.12.2008 |
Неактивен |
3736 |
| Macrogol, combinations |
20060822 |
ENDOFALK, Powder for oral solution, 52.5, g, Pack: 6 |
Dr. Falk Pharma GmbH, Германия |
Dr. Falk Pharma GmbH - Germany |
14.14 |
2.83 |
16.97 |
6% |
0.85 |
14.99 |
3 |
17.99 |
18% |
2.55 |
17.54 |
3.51 |
21.05 |
Промяна на обстоятелства НСР-13979/25.09.2017; НСР-16103/13.07.2018 |
КЦРР-1094/26.07.2012; НСР-16104/13.07.2018 |
02.08.2018 |
02.08.2018 |
Активен |
1310 |
| Macrogol, combinations |
20060822 |
ENDOFALK, Powder for oral solution, 52.5, g, Pack: 6 |
Dr. Falk Pharma GmbH, Германия |
Dr. Falk Pharma GmbH - Germany |
10.07 |
2.01 |
12.08 |
6% |
0.6 |
10.67 |
2.13 |
12.8 |
18% |
1.81 |
12.48 |
2.5 |
14.98 |
Промяна на обстоятелства НСР-13979/25.09.2017 |
КЦРР-1094/26.07.2012 |
10.08.2012 |
02.11.2017 |
Неактивен |
1310 |
| Macrogol, combinations |
5378/ 13.07.2009 |
ENDOFALK, Powder for oral solution, 52.5, g, Pack: 6 |
Dr. Falk Pharma GmbH, Германия |
Dr. Falk Pharma GmbH - Germany |
10.07 |
2.01 |
12.08 |
6% |
0.6 |
10.67 |
2.13 |
12.8 |
18% |
1.81 |
12.48 |
2.5 |
14.98 |
|
КЦРР-1094/26.07.2012 |
10.08.2012 |
10.08.2012 |
Неактивен |
1310 |
| Macrogol, combinations |
5378/13.07.2009 |
ENDOFALK, Powder for oral solution, 52.5, g, Pack: 6 |
Dr. Falk Pharma GmbH, Германия |
Dr. Falk Pharma GmbH - Germany |
12.3 |
2.46 |
14.76 |
8% |
0.98 |
13.28 |
2.66 |
15.94 |
20% |
2.46 |
15.74 |
3.15 |
18.89 |
|
КЦ-1412/22.02.2010 |
10.03.2010 |
10.03.2010 |
Неактивен |
1310 |
| Cyclophosphamide |
20020299 |
Endoxan, Powder for solution for injection, 500, mg, Pack: 1 |
Екофарм Груп АД, България |
Екофарм ЕООД, България |
20.73 |
4.15 |
24.88 |
6% |
1.24 |
21.97 |
4.39 |
26.36 |
18% |
3.73 |
25.7 |
5.14 |
30.84 |
|
НСР-13864/14.09.2017 |
29.09.2017 |
02.10.2017 |
Активен |
15853 |
| Cyclophosphamide |
II-1256/13.12.2007 |
ENDOXAN, Powder for solution for injection, 200, mg, Pack: 10 |
Екофарм Груп АД, България |
Екофарм ЕООД, България |
41.46 |
8.29 |
49.75 |
4% |
1.66 |
43.12 |
8.62 |
51.74 |
16% |
6.63 |
49.75 |
9.95 |
59.7 |
промяна обстоятелства НСР-13370/28.07.2017; НСР-13712/01.09.2017 |
КЦРР-2309/20.02.2013; НСР-15268/16.03.2018 |
08.03.2013 |
02.04.2018 |
Заличен |
1666 |
| Cyclophosphamide |
II-1256/13.12.2007 |
ENDOXAN, Powder for solution for injection, 200, mg, Pack: 10 |
Екофарм Груп АД, България |
Екофарм ЕООД, България |
41.46 |
8.29 |
49.75 |
4% |
1.66 |
43.12 |
8.62 |
51.74 |
16% |
6.63 |
49.75 |
9.95 |
59.7 |
промяна обстоятелства НСР-13370/28.07.2017; НСР-13712/01.09.2017 |
КЦРР-2309/20.02.2013 |
08.03.2013 |
02.10.2017 |
Неактивен |
1666 |
| Cyclophosphamide |
II-1256/13.12.2007 |
ENDOXAN, Powder for solution for injection, 200, mg, Pack: 10 |
Екофарм Груп АД, България |
Baxter Oncology GmbH - Germany |
41.46 |
8.29 |
49.75 |
4% |
1.66 |
43.12 |
8.62 |
51.74 |
16% |
6.63 |
49.75 |
9.95 |
59.7 |
промяна обстоятелства НСР-13370/28.07.2017 |
КЦРР-2309/20.02.2013 |
08.03.2013 |
02.09.2017 |
Неактивен |
1666 |
| Cyclophosphamide |
II-1256/13.12.2007 |
ENDOXAN, Powder for solution for injection, 200, mg, Pack: 10 |
Baxter Oncolcogy GmbH, Германия |
Baxter Oncology GmbH - Germany |
41.46 |
8.29 |
49.75 |
4% |
1.66 |
43.12 |
8.62 |
51.74 |
16% |
6.63 |
49.75 |
9.95 |
59.7 |
|
КЦРР-2309/20.02.2013 |
08.03.2013 |
08.03.2013 |
Неактивен |
1666 |
| Cyclophosphamide |
II-1255/ 13.12.2007 |
ENDOXAN, Powder for solution for injection, 200, mg, Pack: 10 |
Baxter Oncolcogy GmbH, Германия |
Baxter Oncology GmbH - Germany |
42.19 |
8.44 |
50.63 |
4% |
1.69 |
43.88 |
8.78 |
52.66 |
16% |
6.75 |
50.63 |
10.13 |
60.76 |
|
КЦ-950/10.06.2009 |
30.06.2009 |
30.06.2009 |
Неактивен |
1666 |
| Cyclophosphamide |
II-1256/13.12.2007 |
ENDOXAN, Powder for solution for injection, 500, mg, Pack: 1 |
Baxter Oncolcogy GmbH, Германия |
Baxter Oncology GmbH - Germany |
3.77 |
0.75 |
4.52 |
7% |
0.26 |
4.03 |
0.81 |
4.84 |
20% |
0.75 |
4.78 |
0.96 |
5.74 |
Цената се вписва в регистъра на пределните цени с решение НСР-2722/06.02.2014 |
КЦРР-2309/20.02.2013 |
08.03.2013 |
08.03.2013 |
Заличен |
1667 |
| Cyclophosphamide |
II-1256/ 13.12.2007 |
ENDOXAN, Powder for solution for injection, 500, mg, Pack: 1 |
Baxter Oncolcogy GmbH, Германия |
Baxter Oncology GmbH - Germany |
4.19 |
0.84 |
5.03 |
7% |
0.29 |
4.48 |
0.9 |
5.38 |
20% |
0.84 |
5.32 |
1.06 |
6.38 |
|
КЦ-950/10.06.2009 |
30.06.2009 |
30.06.2009 |
Неактивен |
1667 |
| Trimetazidine |
20110185 |
Energotrim, Modified release tablet, 35, mg, Pack: 60 |
Sandoz d.d., Словения |
Lupin (Europe)Ltd., Victoria Court, bexton Road, Knutsford, Cheshire, WA160PF, United Kingdom |
7.76 |
1.55 |
9.31 |
7% |
0.54 |
8.3 |
1.66 |
9.96 |
20% |
1.55 |
9.85 |
1.97 |
11.82 |
|
НСР-3198/07.04.2014; НСР-9769/14.07.2016 |
21.04.2014 |
02.08.2016 |
Заличен |
2682 |
| Trimetazidine |
20110185 |
Energotrim, Modified release tablet, 35, mg, Pack: 60 |
Sandoz d.d., Словения |
Lupin (Europe)Ltd., Victoria Court, bexton Road, Knutsford, Cheshire, WA160PF, United Kingdom |
7.76 |
1.55 |
9.31 |
7% |
0.54 |
8.3 |
1.66 |
9.96 |
20% |
1.55 |
9.85 |
1.97 |
11.82 |
|
НСР-3198/07.04.2014 |
21.04.2014 |
21.04.2014 |
Неактивен |
2682 |
| Trimetazidine |
20110185 |
Energotrim, Modified release tablet, 35, mg, Pack: 60 |
Sandoz d.d., Словения |
Lupin (Europe)Ltd., Victoria Court, bexton Road, Knutsford, Cheshire, WA160PF, United Kingdom |
7.94 |
1.59 |
9.53 |
7% |
0.56 |
8.5 |
1.7 |
10.2 |
20% |
1.59 |
10.09 |
2.02 |
12.11 |
|
КЦРР-1718/28.11.2012 г |
01.01.2013 |
01.01.2013 |
Неактивен |
2682 |
| Hepatitis B, purified antigen |
20000247 |
Engerix B, Suspension for injection, 20 mcg/1.0 ml, -, Pack: 1 pre-filled syringe |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals s.a., Белгия |
16.7 |
3.34 |
20.04 |
6% |
1 |
17.7 |
3.54 |
21.24 |
18% |
3.01 |
20.71 |
4.14 |
24.85 |
|
КЦРР-2557/14.03.2013; НСР-12476/28.04.2017 г.; НСР-16124/13.07.2018; НСР-18291/28.03.2019 |
12.04.2019 |
02.05.2019 |
Активен |
1730 |
| Hepatitis B, purified antigen |
20000247 |
Engerix B, Suspension for injection, 20 mcg/1.0 ml, -, Pack: 1 pre-filled syringe |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals s.a., Белгия |
16.76 |
3.35 |
20.11 |
6% |
1.01 |
17.77 |
3.55 |
21.32 |
18% |
3.02 |
20.79 |
4.16 |
24.95 |
|
КЦРР-2557/14.03.2013; НСР-12476/28.04.2017 г.; НСР-16124/13.07.2018 |
28.07.2018 |
02.08.2018 |
Неактивен |
1730 |
| Hepatitis B, purified antigen |
20000246 |
Engerix B, Suspension for injection, 10 mcg/0.5 ml, -, Pack: 1 pre-filled syringe |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium |
11.85 |
2.37 |
14.22 |
6% |
0.71 |
12.56 |
2.51 |
15.07 |
18% |
2.13 |
14.69 |
2.94 |
17.63 |
|
НСР-8323/26.02.2016; НСР-10750/27.10.2016; НСР-13274/20.07.2017; НСР-17028/19.10.2018 |
03.11.2018 |
02.12.2018 |
Активен |
2998 |
| Hepatitis B, purified antigen |
20000246 |
Engerix B, Suspension for injection, 10 mcg/0.5 ml, -, Pack: 1 pre-filled syringe |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium |
11.93 |
2.39 |
14.32 |
6% |
0.72 |
12.65 |
2.53 |
15.18 |
18% |
2.15 |
14.8 |
2.96 |
17.76 |
|
НСР-8323/26.02.2016; НСР-10750/27.10.2016; НСР-13274/20.07.2017 |
04.08.2017 |
02.09.2017 |
Неактивен |
2998 |